Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges

Molecular Pharmaceutics

Volumn 7, Issue 6, 2010, Pages 2030-2039

  Verenich, Svetlana ^a   Gerk, Phillip M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL;

ANTINEOPLASTIC ACTIVITY; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG GLUCURONIDATION; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SOLUBILITY; GLOMERULOSCLEROSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG STABILITY; ESTRADIOL; HUMANS; NEOPLASMS;

EID: 78649948637     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp100190f     Document Type: Review

References (59)

1. Martucci, C. P. Metabolic Fate of Catechol Estrogens. In Catechol Estrogens; Merriam, G. R., Lipsett, M. B., Eds.; Raven Press: New York, 1983; pp 115 - 121.
2. Lakhani, N. J.; Sarkar, M. A.; Venitz, J.; Figg, W. D. 2-Methoxyestradiol, a Promising Anticancer Agent Pharmacotherapy 2003, 23, 165-172
3. Dubey, R. K.; Jackson, E. K. Potential Vascular Actions of 2-Methoxyestradiol Trends Endocrinol. Metab. 2009, 20, 374-379
4. Parl, F. F.; Egan, K. M.; Li, C.; Crooke, P. S. Estrogen Exposure, Metabolism, and Enzyme Variants in a Model for Breast Cancer Risk Prediction Cancer Informatics 2009, 7, 109-121
5. Lee, A. J.; Cai, M. X.; Thomas, P. E.; Conney, A. H.; Zhu, B. T. Characterization of the Oxidative Metabolites of 17-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoform Endocrinology 2003, 144, 3382-3398
6. Paul, S. M.; Purdy, R. H.; Hoffman, A. K.; Axelrod, J. Radioenzymatic Assays for Catechol Estrogens. In Catechol Estrogens; Merriam, G. R.; Lipsett, M. B., Eds.; Raven Press: New York, 1983; pp 83 - 90.
7. Lakhani, N. J.; Sparreboom, A.; Xu, X.; Veenstra, T. D.; Venitz, J.; Dahut, W. L.; Figg, W. D. Characterization of in Vitro and in Vivo Metabolic Pathways of the Investigational Anticancer Agent, 2-Methoxyestradiol J. Pharm. Sci. 2007, 96, 1821-1831
8. Männisto, P. K.; Kaakkola, S. Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors Pharmacol. Rev. 1999, 51, 593-628
9. Berg, D.; Sonsalla, R.; Kuss, E. Concentration of 2-Methoxyestrogens in Human Serum measured by a Heterologous Immunoassay with 125I-labled Ligand Acta Endocrinol. 1983, 103, 282-288
10. Xu, X.; Roman, J. M.; Issaq, H. J.; Keefer, L. K.; Veenstra, T. D.; Ziegler, R. G. Quantitative Measurement of Endogenous Estrogens and Estrogen Metabolites in Human Serum by Liquid Chromatography-Tandem Mass Spectrometry Anal. Chem. 2007, 79, 7813-7821 (Pubitemid 47622412)
11. Arendt, K. W.; Garovic, V. D. Association of Deficiencies of Catechol-O-methyltransferase and 2-Methoxyestradiol with Preeclampsia Expert Rev. Obstet. Gynecol. 2009, 4, 379-381
12. Kanasaki, K.; Palmisten, K.; Sugimoto, H.; Ahmad, S.; Hamano, Y.; Xie, L.; Parry, S.; Augustin, H. G.; Gattone, V. H., Jr.; Folkman, J.; Strauss, J. F.; Kalluri, R. Deficiency in Catechol-O-methyltransferase and 2-Methoxyestradiol is Associated with Pre-eclampsia Nature 2008, 453, 1117-1121
13. Dahut, W. L.; Lakhani, N. J.; Gulley, J. L.; Arlen, P. M.; Kohn, E. C.; Kotz, H.; McNally, D.; Parr, A.; Nguyen, D.; Yang, S. X.; Steinberg, S. M.; Venitz, J.; Sparreboom, A.; Figg, W. D. Phase I Clinical Trial of Oral 2-Methoxyestradiol, an Antiangiogenic and Apoptotic Agent, in Patients with Solid Tumors Cancer Biol. Ther. 2006, 5, 22-27
14. Sweeney, C.; Liu, G.; Yiannoutsos, C.; Kolesar, J.; Horvath, D.; Staab, M. J.; Fife, K.; Armstrong, V.; Treston, A.; Sidor, C.; Wilding, G. A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer Clin. Cancer Res. 2005, 11, 6625-6633
15. James, J.; Murry, D. J.; Treston, A. M.; Storniolo, A. M.; Sledge, G. W.; Sidor, C.; Miller, K. D. Phase I Safety, Pharmacokinetic and Pharmacodynamic Studies of 2-Methoxyestradiol Alone or in Combination with Docetaxel in Patients with Locally Recurrent or Metastatic Breast Cancer Invest. New Drugs 2006, 25, 41-48
16. Rajkumar, S. V.; Richardson, P. G.; Lacy, M. Q.; Dispenzieri, A.; Greipp, P. R.; Witzig, T. E.; Schlossman, R.; Sidor, C. F.; Anderson, K. C.; Gertz, M. A. Novel Therapy with 2-Methoxyestradiol for the Treatment of Relapsed and Plateau Phase Multiple Myeloma Clin. Cancer Res. 2007, 13, 6162-6167
17. Pribluda, V. S.; Gubish, E. R.; LaVallee, T. M.; Treston, A.; Swartz, G. M.; Green, S. J. 2-Methoxyestradiol: an Endogenous Antiangiogenic and Antiproliferative Drug Candidate Cancer Metastasis Rev. 2000, 19 (1/2) 173-179
18. Papathanassiu, A. E.; Green, S. J.; Grella, D. K.; Sim, B. K. L. Methoxyestradiol. In Cytokine Reference: a Compendium of Cytokines and Other Mediators of Host Defense; Feldmann, M.; Oppenheim, J. J.; Durum, S. K., Eds.; Academic Press: San Diego, 2001; pp 835 - 839.
19. Thaver, V.; Lottering, M.-L.; van Papendorp, D.; Joubert, A. in Vitro Effects of 2-Methoxyestradiol on Cell Numbers, Morphology, Cell Cycle Progression, and Apoptosis Induction in Oesophageal Carcinoma Cells Cell Biochem. Funct. 2009, 27, 205-210
20. Zhou, N.-N.; Zhu, X.-F.; Zhou, J.-M.; Li, M.-Z.; Zhang, X.-S.; Huang, P.; Jiang, W.-Q. 2-Methoxyestradiol Induces Cell Cycle Arrest and Apoptosis of Nasopharyngeal Carcinoma Cells Acta Pharmacol. Sin. 2004, 25, 1515-1520
21. Salama, S. A.; Nasr, A. B.; Dubey, R. K.; Al-Hendy, A. Estrogen Metabolite 2-Methoxyestradiol Induces Apoptosis and Inhibits Cell Proliferation and Collagen Production in Rat and Human Leiomyoma Cells: A Potential Medicinal Treatment for Uterine Fibroids J. Soc. Gynecol. Investig. 2006, 13, 542-549
22. Chamaon, K.; Stojek, J.; Kanakis, D.; Braeuninger, S.; Kirches, E.; Krause, G.; Mawrin, C.; Dietzmann, K. Micromolar Concentrations of 2-Methoxyestradiol Kill Glioma Cells by an Apoptotic Mechanism, without Destroying Their Microtubule Cytoskeleton J. Neuro. Oncol. 2005, 72, 11-16
23. Abou El Naga, R. N.; El-Demerdash, E.; Youssef, S. S.; Abdel-Naim, A. B.; El-Merzabani, M. Cytotoxic Effects of 2-Methoxyestradiol in the Hepatocellular Carcinoma Cell Line HepG2 Pharmacology 2009, 84, 9-16
24. Li, L.; Heldin, N.-E.; Grawé, J.; Ulmsten, U.; Fu, X. Induction of Apoptosis or Necrosis in Human Endometrial Carcinoma Cells by 2-Methoxyestradiol Anticancer Res. 2004, 24, 3983-3990 (Pubitemid 40468697)
25. LaVallee, T. M.; Zhan, X. H.; Herbstritt, C. J.; Kough, E. C.; Green, S. J.; Pribluda, V. S. 2-Methoxyestradiol Inhibits Proliferation and Induces Apoptosis Independently of Estrogen Receptors α and β Cancer Res. 2002, 62, 3691-3697
26. Liu, Z.-J.; Zhu, B. T. Concentration-dependent Mitogenic and Antiproliferative Actions of 2-Methoxyestradiol in Estrogen Receptor-positive Human Breast Cancer Cells J. Steroid Biochem. Mol. Biol. 2004, 88, 265-275
27. Tsukamoto, A.; Kaneko, Y.; Yoshida, T. 2-Methoxyestradiol, an Endogenous Metabolite of Estrogen, Enhances Apoptosis and β-Galactosidase Expression in Vascular Endothelial Cells Biochem. Biophys. Res. Commun. 1998, 248, 9-12
28. Xiao, S.; Gillespie, D. G.; Baylis, C.; Jackson, E. K.; Dubey, R. K. Effects of Estradiol and Its Metabolites on Glomerular Endothelial Nitric Oxide Synthesis and Mesangial Cell Growth Hypertension 2001, 37, 645-650
29. Kurokawa, A.; Azuma, K.; Mita, T.; Toyofuko, Y.; Fujitani, Y.; Hirose, T.; Iwabuchi, K.; Ogawa, H.; Takeda, S.; Kawamori, R.; Watada, H. 2-Methoxyestradiol Reduces Monocyte Adhesion to Aortic Endothelial Cells in Ovariectomized Rats Endocr. J. 2007, 54, 1027-1031
30. Dubey, R. K.; Imthurn, B.; Jackson, E. K. 2-Methoxyestradiol: a Potential Treatment for Multiple Proliferative Disorders Endocrinology 2007, 148, 4125-4127
31. Squillace, D. P.; Reid, J. M.; Kuffel, M. J.; Ames, M. M. Bioavailability and in vivo Metabolism of 2-Methoxyestradiol in Mice Proc. Am. Assoc. Cancer Res. 1998, 39, 523
32. 11C] Methoxyestradiol: Synthesis, Evaluation and Pharmacokinetics for in Vivo Studies on Angiogenesis Nucl. Med. Biol. 2007, 34, 625-631
33. Ireson, C. R.; Chander, S. K.; Purohit, A.; Perera, S.; Newman, S. P.; Parish, D.; Leese, M. P.; Smith, A. C.; Potter, B. V. L.; Reed, M. J. Pharmacokinetics and Efficacy of 2-Methoxyoestradiol and 2-Methoxyoestradiol- bis-sulphamate in Vivo in Rodents Br. J. Cancer 2004, 90, 932-937
34. Zacharia, L. C.; Piché, C. A.; Fielding, R. M.; Holland, K. M.; Allison, S. D.; Dubey, R. K.; Jackson, E. K. 2-Hydroxyestradiol is a Prodrug of 2-Methoxyestradiol J. Pharmacol. Exp. Ther. 2004, 309, 1093-1097
35. Lakhani, N.; Sparreboom, A.; Venitz, J.; Dahut, W. L.; Figg, W. D. Plasma Protein Binding of the Investigational Anticancer Agent 2-Methoxyestradiol Anti-Cancer Drugs 2006, 17, 977-983
36. Lakhani, N. J. Evaluation of the Pharmacokinetic-Pharmacodynamic Relationship, Metabolism and Plasma Protein Binding of the Novel Antitumor Agent, 2-Methoxyestradiol (2ME2) Following Oral Administration in the Patients with Solid Tumors. PhD Diss., Virginia Commonwealth University, 2005.
37. Basu, N. K.; Kubota, S.; Meselhy, M. R.; Ciotti, M.; Chowdhury, B.; Hartori, M.; Owens, I. S. Gastrointestinally Distributed UDP- glucuronosyltransferase 1A10, Which Metabolizes Estrogens and Nonsteroidal Anti-inflammatory Drugs, Depends upon Phosphorylation J. Biol. Chem. 2004, 279, 28320-28329
38. Lépine, J.; Bernard, O.; Plante, M.; Têtu, B.; Pelletier, G.; Labrie, F.; Bélanger, A.; Guillemette, C. Specificity and Regioselectivity of the Conjugation of Estradiol, Estrone, and Their Catecholestrogen and Methoxyestrogen Metabolites by Human Uridine Diphospho-glucuronosyltransferases Expresses in Endometrium J. Clin. Endocrin. Metab. 2004, 89, 5222-5232
39. Ritter, J. K.; Sheen, Y. Y.; Lubet, R. A.; Owens, I. S. Cloning and Expression of Human Liver UDP-Glucuronosyltransferase in COS-1 Cells. 3,4-Catechol Estrogens and Estriol as Primary Substrates J. Biol. Chem. 1990, 265, 7900-7906
40. Gall, W. E.; Zawada, G.; Mojarrabi, B.; Tephly, T. R.; Green, M. D.; Coffman, B. L.; Mackenzie, P. I.; Radominska-Pandya, A. Differential Glucuronidation of Bile Acids, Androgen and Estrogen by Human UGT1A3 and 2B7 J. Steroid Biochem. Mol. Biol. 1999, 70, 101-108
41. Basu, N. K.; Ciotti, M.; Hwang, M. S.; Kole, L.; Mitra, P. S.; Cho, J. W.; Owens, I. S. Differential and Special Properties of the Major Human UGT1-encoded Gastrointestinal UDP-glucuronosyltrasferases Enhance Potential to Control Chemical Uptake J. Biol. Chem. 2004, 279, 1429-1441
42. Spink, B. C.; Katz, B. H.; Hussain, M. M.; Pang, S.; Connor, S. P.; Aldous, K. M.; Gierthy, J. F.; Spink, D. C. SULT1A1 Catalyzes 2-Methoxyestradiol Sulfonation in MCF-7 Breast Cancer Cells Carcinogenesis 2000, 21, 1946-1957
43. Schinkel, A. H.; Jonker, J. W. Mammalian Drug Efflux Transporters of the ATP Binding Cassette (ABC) Family: an Overview Adv. Drug Delivery Rev. 2003, 55, 3-29
44. Fujise, H.; Annoura, T.; Sasawatari, S.; Ikeda, T.; Ueda, K. Transepithelial Transport and Cellular Accumulation of Steroid Hormones and Polychlorobiphenyl in Porcine Kidney Cells Expressed with Human P-glycoprotein Chemosphere 2002, 46, 1505-1511
45. Janvilisri, T.; Venter, H.; Shahi, S.; Reuter, G.; Balakrishnan, L.; van Veen, H. W. Sterol Transport by the Human Breast Cancer Resistance Protein (ABCG2) Expressed in Lactococcus lactis J. Biol. Chem. 2003, 278, 20645-20651
46. Imai, Y.; Tsukahara, S.; Ishikawa, E.; Tsuruo, T.; Sugimoto, Y. Estrone and 17β-Estradiol Reverse Breast Cancer Resistance Protein-Mediated Multidrug Resistance Jpn. J. Cancer Res. 2002, 93, 231-235
47. Fishman, W. H.; Anlyan, A. J. The presence of high beta-glucuronidase activity in cancer tissue J. Biol. Chem. 1947, 169, 449-50
48. Murdter, T. E.; Sperker, B.; Kivisto, K. T.; McClellan, M.; Fritz, P.; Friedel, G.; Linder, A.; Bosslet, K.; Toomes, H.; Dierkesmann, R.; Kroemer, H. K. Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site Cancer Res. 1997, 57, 2440-2445
49. Wang, S. H.; Shi, Z.; Chen, X.; Baker, J. R., Jr. Therapeutic Efficacy of 2-Methoxyestradiol Microcrystal Encapsulated within Polyelectrolyte Multilayers Macromol. Biosci. 2009, 9, 429-436
50. Tevaarwerk, A. J.; Holen, K. D.; Alberti, D. B.; Sidor, C.; Arnott, J.; Quon, C.; Wilding, G.; Liu, G. Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies Clin. Cancer Res. 2009, 15, 1460-1465
51. Cushman, M.; He, H.-M.; Katzenellenbogen, J. A.; Varma, R. K.; Hamel, E.; Lin, C. M.; Ram, S.; Sachdeva, Y. P. Synthesis of Analogs of 2-Methoxyestradiol with Enhanced Inhibitory Effects on Tubulin Polymerization and Cancer Cell Growth J. Med. Chem. 1997, 40, 2323-2334
52. Agoston, G. E.; Shah, J. H.; LaVallee, T. M.; Zhan, X.; Pribluda, V. S.; Treston, A. M. Synthesis and Structure-Activity Relationships of 16-modified analogs of 2-Methoxyestradiol Bioorg. Med. Chem. 2007, 15, 7524-7537
53. Cushman, M.; Mohanakrishnan, A. K.; Hollingshead, M.; Hamel, E. The Effect of Exchanging Various Substituents at the 2-Position of 2-Methoxyestradiol on Cytotoxicity in Human Cancer Cell Cultures and Inhibition of Tubulin Polymerization J. Med. Chem. 2002, 45, 4748-4654
54. Suwandi, L. S.; Agoston, G. E.; Shah, J. H.; Hanson, A. D.; Zhan, X. H.; LaVallee, T. M.; Treston, A. M. Synthesis and Antitumor Activities of 3-Modified 2-Methoxyestradiol Analogs Bioorg. Med. Chem. Lett. 2009, 19, 6459-6462
55. Shah, J. H.; Agoston, G. E.; Suwandi, L.; Hunsucker, K.; Pribluda, V.; Zhan, X. H.; Swartz, G. M.; LaVallee, T. M.; Treston, A. M. Synthesis of 2- and 17-Substituted Estrone Analogs and Their Antiproliferative Structure-Activity Relationships Compared to 2-Methoxyestradiol Bioorg. Med. Chem. 2009, 17, 7344-7352
56. Agoston, G. E.; Shah, J. H.; Suwandi, L.; Hanson, A. D.; Zhan, X.; LaVallee, T. M.; Pribluda, V.; Treston, A. M. Synthesis, Antiproliferative, and Pharmacokinetic Properties of 3- and 17-double Modified Analogs of 2-Methoxyestradiol Bioorg. Med. Chem. Lett. 2009, 19, 6241-6244
57. Raobaikady, B.; Purohit, A.; Chander, S. K.; Woo, L. W. L.; Leese, M. P.; Potter, B. V. L.; Reed, M. J. Inhibition of MCF-7 Breast Cancer Cell Proliferation and in Vivo Steroid Sulfatase Activity by 2-Methoxyoestradiol-bis- sulphamate J. Steroid Biochem. Mol. Biol. 2003, 84, 351-358
58. Newman, S. P.; Leese, M. P.; Purohit, A.; James, D. R. C.; Renne, C. E.; Potter, B. V. L.; Reed, M. J. Inhibition on in Vitro Angiogenesis by 2-Methoxy- and 2-Ethyl-Estrogen Sulfamates Int. J. Cancer 2004, 109, 533-540
59. Edsall, A,. B.; Agoston, G. E.; Treston, A. M.; Plum, S. M.; McClanahan, R. H.; Lu, T.-S.; Song, W.; Cushman, M. Synthesis and in Vivo Antitumor Evaluation of 2-Methoxyestradiol 3-Phosphate, 17-Phosphate, and 3,17-Phosphate J. Med. Chem. 2007, 50, 6700-6705